It does not replace medical advice, diagnosis, treatment, prescription instructions, pharmacy labeling, or provider guidance
However, the Food and Drug Administration (FDA) has not yet approved generic semaglutide
If you do tear or cut the patch, dont use it
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, et al
Generic Semaglutide Enters India: Competition, Innovation, and Market Disruption Executive Summary India is entering a pivotal phase in metabolic care as generic semaglutide launches are planned immediately following patent expiry in late March 2026
Rare but more serious risks include pancreatitis, vision changes and allergic reactions